Adjuvant treatment combining cellular immunotherapy with chemotherapy improves the clinical outcome of patients with stage II/III gastric cancer

Postsurgical relapse remains a common issue for resectable gastric cancer (GC). Here, we investigated the efficacy and safety of an adjuvant treatment combining chemotherapy with cellular immunotherapy (CIT) using autologous natural killer cells, γδT cells, and cytokine‐induced killer cells in the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yizhuo, Wang, Chang, Xiao, Huijie, Niu, Chao, Wu, Haitao, Jin, Haofan, Yao, Cheng, He, Hua, Tian, Huimin, Han, Fujun, Li, Dan, Han, Wei, Xu, Jianting, Chen, Jingtao, Cui, Jiuwei, Li, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269688/
https://www.ncbi.nlm.nih.gov/pubmed/27790867
http://dx.doi.org/10.1002/cam4.942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269688/
https://www.ncbi.nlm.nih.gov/pubmed/27790867
http://dx.doi.org/10.1002/cam4.942

Ejemplares similares